Триггеры аллергических реакций в женском генитальном тракте и современные методы диагностики сенсибилизации

1. Moraes P.S., Taketomi E.A. Allergic vulvovaginitis. Ann. Allergy Asthma Immunol. 2000; 85(4): 253-65; quiz 265-7. https://dx.doi.org/10.1016/S1081-1206(10)62527-6
2. Paladine H.L., Desai U.A. Vaginitis: diagnosis and treatment. Am. Fam. Physician. 2018; 97: 321-9.
3. Hildebrand J.P., Carlson K., Kansagor A.T. Vaginitis. In: StatPearls
4. Harper J., Zirwas M. Allergic contact dermatitis of the vagina and perineum: causes, incidence of, and differentiating factors. Clin. Obstet. Gynecol. 2015; 58: 153-7. https://dx.doi.org/10.1097/GRF.0000000000000094
5. Woodruff C.M., Trivedi M.K., Botto N., Kornik R. Allergic contact dermatitis of the vulva. Dermatitis. 2018; 29(5): 233-43. https://dx.doi.org/10.1097/DER.0000000000000339
6. Чернова Н.И., Перламутров Ю.Н., Задорожная И.С., Носова Д.Б. Аллергия и рецидивирующий вульвовагинит. Доктор.Ру. 2020; 19(8): 91-5.
7. Oliveira A.S., Rolo J., Gaspar C., Palmeira de Oliveira R., Martinez de Oliveira J., Palmeira de Oliveira A. Allergic vulvovaginitis: a systematic literature review. Arch. Gynecol. Obstet. 2022; 306(3): 593-622. https://dx.doi.org/10.1007/s00404-021-06332-z
8. Abe S., Ohtsubo H.
9. Chong K.Y, Tyagi-Bhatia J. Vulval fixed drug eruption following trimethoprim use. BMJ Case Rep. 2025; 18(2): e264098. https://dx.doi.org/10.1136/bcr-2024-264098
10. Павлова А.А., Долгушина Н.В., Латышева Е.А., Ковалева А.А., Колодько В.Г. Значение аллергии в развитии хронического вульвовагинита. Акушерство и гинекология. 2015; 9: 68-74.
11. Павлова А.А., Долгушина Н.В., Донников А.Е., Бурменская О.В., Иванец Т.Ю., Латышева Е.А. Оценка экспрессии и полиморфизма генов цитокинов как предикторов хронического вульвовагинита, ассоциированного с аллергическим воспалением. Акушерство и гинекология. 2016; 3: 64-70.
12. Crowder C.A., Jeney S.E.S., Kraus C.N., Bernal N., Lane F. Vulvovaginal involvement in Stevens – Johnson syndrome and toxic epidermal necrolysis: management and techniques used to reduce gynecologic sequelae. Int. J. Dermatol. 2022; 61(2): 158-63. https://dx.doi.org/10.1111/ijd.15676
13. DenAdel M.A., Hendrickson S.E., Fuchs E. Stevens Johnson syndrome: past, present, and future directions gynecologic manifestations and management in SJS / TEN. Front. Med. (Lausanne). 2022; 9: 874445. https://dx.doi.org/10.3389/fmed.2022.874445
14. Eubel J., Diepgen T.L., Weisshaar E.
15. Peckruhn M., Elsner P.
16. Jutel M., Agache I., Zemelka-Wiacek M., Akdis M., Chivato T., Del Giacco S. et al. Nomenclature of allergic diseases and hypersensitivity reactions: adapted to modern needs: an EAACI position paper. Allergy. 2023; 78(11): 2851-74. https://dx.doi.org/10.1111/all.15889
17. Lavery W.J., Stevenson M., Bernstein J.A. An overview of seminal plasma hypersensitivity and approach to treatment. J. Allergy Clin. Immunol. Pract. 2020; 8(9): 2937-42. https://dx.doi.org/10.1016/j.jaip.2020.04.067
18. Schacher K., Dalloul M., Muneyyirci-Delale O. Seminal plasma hypersensitivity: a systematic review of clinical presentation, diagnostics, and management options. Am. J. Reprod. Immunol. 2024; 91(5): e13865. https://dx.doi.org/10.1111/aji.13865
19. Glatzel V., Bertlich M., Oppel E.M. Seltene allergie auf sperma.
20. Schlosser B.J. Contact dermatitis of the vulva. Dermatol. Clin. 2010; 28(4): 697-706. https://dx.doi.org/10.1016/j.det.2010.08.006
21. von der Gathen Y., Sander I., Flagge A., Brüning T., Raulf-Heimsoth M. Quantification of protein and latex allergen content of various natural rubber latex products. Allergol. Select. 2017; 1(2): 109-19. https://dx.doi.org/10.5414/ALX01461E
22. Carra S., Schatz M., Mertes P.M., Torres M.J., Fuchs F., Senna G. et al. Anaphylaxis and pregnancy: a systematic review and call for public health actions. J. Allergy Clin. Immunol. Pract. 2021; 9(12): 4270-8. https://dx.doi.org/10.1016/j.jaip.2021.07.046
23. Foote C.A., Brady S.P., Brady K.L., Clark N.S., Mercurio M.G. Vulvar dermatitis from allergy to moist flushable wipes. J. Low Genit. Tract Dis. 2014; 18(1): E16-8. https://dx.doi.org/10.1097/LGT.0b013e31828e499f
24. Slodownik D., Bar J., Daniely D. Trends in contact sensitization, results, and implications from a contact dermatitis clinic in Israel. Contact Dermatitis. 2024; 90(6): 556-65. https://dx.doi.org/10.1111/cod.14524
25. Haverhoek E., Reid C., Gordon L., Marshman G., Wood J., Selva-Nayagam P. Prospective study of patch testing in patients with vulval pruritus. Australas J. Dermatol. 2008; 49(2): 80-5. https://dx.doi.org/10.1111/j.1440-0960.2008.00442.x
26. Corazza M., Virgili A., Toni G., Minghetti S., Tiengo S., Borghi A. Level of use and safety of botanical products for itching vulvar dermatoses. Are patch tests useful? Contact Dermatitis. 2016; 74(5): 289-94. https://dx.doi.org/10.1111/cod.12559
27. Lucke T.W., Fleming C.J., McHenry P., Lever R. Patch testing in vulval dermatoses: how relevant is nickel? Contact Dermatitis. 1998; 38(2): 111-2. https://dx.doi.org/10.1111/j.1600-0536.1998.tb05666.x
28. Vandeweege S., Debaene B., Lapeere H., Verstraelen H. A systematic review of allergic and irritant contact dermatitis of the vulva: the most important allergens / irritants and the role of patch testing. Contact Dermatitis. 2023; 88(4): 249-62. https://dx.doi.org/10.1111/cod.14258
29. Cheng H.S., Fernández-Peñas P. Allergic contact dermatitis of the anogenital region in men and women. J. Low Genit. Tract Dis. 2020; 24(2): 221-4. https://dx.doi.org/10.1097/LGT.0000000000000516
30. Yuk J.S., Shin J.S., Shin J.Y., Oh E., Kim H., Park W.I. Nickel allergy is a risk factor for endometriosis: an 11-year population-based nested case-control study. PLOS One. 2015; 10(10): e0139388. https://dx.doi.org/10.1371/journal.pone.0139388
31. Borghini R., Porpora M.G., Casale R., Marino M., Palmieri E., Greco N. et al. Irritable bowel syndrome-like disorders in endometriosis: prevalence of nickel sensitivity and effects of a low-nickel diet. An open-label pilot study. Nutrients. 2020; 12(2): 341. https://dx.doi.org/10.3390/nu12020341
32. Nguyen H.L., Yiannias J.A. Contact dermatitis to medications and skin products. Clin. Rev. Allergy Immunol. 2019; 56(1): 41-59. https://dx.doi.org/10.1007/s12016-018-8705-0
33. Meech R.J., Smith J.M., Chew T. Pathogenic mechanisms in recurrent genital candidosis in women. N. Z. Med. J. 1985; 98(771): 1-5.
34. Witkin S.S., Jeremias J., Ledger W.J. A localized vaginal allergic response in women with recurrent vaginitis. J. Allergy Clin. Immunol. 1988; 81(2): 412-6. https://dx.doi.org/10.1016/0091-6749(88)90909-8
35. Montagnoli C., Bacci A., Bozza S., Gaziano R., Mosci P., Sharpe A.H. et al. B7/CD28-dependent CD4+CD25+ regulatory T cells are essential components of the memory-protective immunity to Candida albicans. J. Immunol. 2002; 169(11): 6298-308. https://dx.doi.org/10.4049/jimmunol.169.11.6298
36. Karakoyun A.S., Unal N., Sucu M., Bingöl O., Unal I., Ilkit M. Integrating clinical and microbiological expertise to improve vaginal candidiasis management. Mycopathologia. 2024; 189(6): 96. https://dx.doi.org/10.1007/s11046-024-00904-8
37. Pereira L.C., Correia A.F., da Silva Z.D.L., de Resende C.N., Brandão F., Almeida R.M. et al. Vulvovaginal candidiasis and current perspectives: new risk factors and laboratory diagnosis by using MALDI TOF for identifying species in primary infection and recurrence. Eur. J. Clin. Microbiol. Infect. Dis. 2021; 40(8): 1681-93. https://dx.doi.org/10.1007/s10096-021-04199-1
38. Neves N.A., Carvalho L.P., De Oliveira M.A., Giraldo P.C., Bacellar O., Cruz A.A. et al. Association between atopy and recurrent vaginal candidiasis. Clin. Exp. Immunol. 2005; 142(1): 167-71. https://dx.doi.org/10.1111/j.1365-2249.2005.02891.x
39. Bernstein J.A., Seidu L. Chronic vulvovaginal candida hypersensitivity: an underrecognized and undertreated disorder by allergists. Allergy Rhinol. (Providence). 2015; 6(1): 44-9. https://dx.doi.org/10.2500/ar.2015.6.0113
40. Talaei Z., Sheikhbahaei S., Ostadi V., Ganjalikhani Hakemi M., Meidani M., Naghshineh E. et al. Recurrent vulvovaginal candidiasis: could it be related to cell-mediated immunity defect in response to candida antigen? Int. J. Fertil. Steril. 2017; 11(3): 134-41. https://dx.doi.org/10.22074/ijfs.2017.4883
41. Burn M.S., Kwah J.H., Son M. Diagnosis and clinical management of drug allergies in obstetrics and gynecology: an expert review. Am. J. Obstet. Gynecol. 2025; 232(3): 243-61. https://dx.doi.org/10.1016/j.ajog.2024.10.025
42. Ozturk S., Caliskaner Z., Karaayvaz M., Dede M., Gulec M. Hypersensitivity to aeroallergens in patients with recurrent vulvovaginitis of undetermined etiology. J. Obstet. Gynaecol. Res. 2007; 33(4): 496-500. https://dx.doi.org/10.1111/j.1447-0756.2007.00578.x
43. Theodoropoulos D.S., Stockdale C.K., Duquette D.R., Morris M.S. Inhalant allergy compounding the chronic vaginitis syndrome: characterization of sensitization patterns, comorbidities and responses to sublingual immunotherapy. Arch. Gynecol. Obstet. 2016; 294(3): 541-8. https://dx.doi.org/10.1007/s00404-016-4081-2
44. Graziottin A., Murina F., Gambini D., Taraborrelli S., Gardella B., Campo M. Vulvar pain: the revealing scenario of leading comorbidities in 1183 cases. Eur. J. Obstet. Gynecol. Reprod. Biol. 2020; 252: 50-5. https://dx.doi.org/10.1016/j.ejogrb.2020.05.052
45. Sompornrattanaphan M., Kreetapirom P., Srinoulprasert Y., Kanistanon D., Klinniyom A., Wongsa C. et al. Severe anaphylaxis after pelvic examination: a case report of dual latex and chlorhexidine allergies. Allergy Asthma Clin. Immunol. 2019; 15: 19. https://dx.doi.org/10.1186/s13223-019-0335-4
46. Nucera E., Pollastrini E., Sabato V., Colagiovanni A., Aruanno A., Rizzi A. et al. Challenge tests in the diagnosis of latex allergy. Int. J. Immunopathol. Pharmacol. 2010; 23(2): 543-52. https://dx.doi.org/10.1177/039463201002300216
47. Зайков С.В., Полищук Ю.В. Диагностика и лечение аллергических заболеваний половых органов. Новости медицины и фармации. 2013; 1(454): 17-21.
48. Cooper L., Harbour J., Sneddon J., Seaton R.A. Seaton safety and efficacy of de-labelling penicillin allergy in adults using direct oral challenge: a systematic review. JAC Antimicrob. Resist. 2021; 3(1): dlaa123. https://dx.doi.org/10.1093/jacamr/dlaa123
49. Siemons S., Vleugels M., van Eijndhoven H. Evaluation of nickel allergic reactions to the Essure micro insert: theoretical risk or daily practice? J. Minim. Invasive Gynecol. 2017; 24(1): 140-4. https://dx.doi.org/10.1016/j.jmig.2016.09.001
50. Jeimy S., Ben-Shoshan M., Abrams E.M., Ellis A.K., Connors L., Wong T. Practical guide for evaluation and management of beta-lactam allergy: position statement from the Canadian society of allergy and clinical immunology. Allergy Asthma Clin. Immunol. 2020; 16(1): 95. https://dx.doi.org/10.1186/s13223-020-00494-2
51. Presti M.P., Druce H.M. Hypersensitivity reactions to human seminal plasma. Ann. Allergy. 1989; 63(6 Pt 1): 477-80.
52. Czarnobilska M., Bulanda M., Czarnobilska E., Dyga W., Mazur M. The role of the basophil activation test in the diagnosis of drug-induced anaphylaxis. Diagnostics (Basel). 2024; 14(18): 2036. https://dx.doi.org/10.3390/diagnostics14182036
53. Bennett M.R., Mathioudakis A.G., Wu J., Chu M.M.H., Tontini C., Thomas I. et al. Performance characteristics of basophil activation tests for diagnosing penicillin allergy: a meta-analysis. J. Allergy Clin. Immunol. Pract. 2024; 12(3): 714-23.e5. https://dx.doi.org/10.1016/j.jaip.2023.11.004
54. Бычкова Н.В. Активация базофилов: теоретические аспекты и применение в диагностике аллергических заболеваний. Медицинская иммунология. 2021; 23(3): 469-82.
55. Testera-Montes A., Ariza A., Sola-Martinez R.A., Aranda C.J., Bentabol-Ramos G., Sanchez-Torralvo D. et al. Investigation of the diagnostic accuracy of basophil activation test for allergic phenotypes of rhinitis. Allergy. 2025; 80(3): 738-49. https://dx.doi.org/10.1111/all.16390
56. Bergmann M.M., Santos A.F. Basophil activation test in the food allergy clinic: its current use and future applications. Expert Rev. Clin. Immunol. 2024; 20(11): 1297-1304. https://dx.doi.org/10.1080/1744666X.2024.2336568
57. Eberlein B. Basophil activation as marker of clinically relevant allergy and therapy outcome. Front. Immunol. 2020; 11: 1815. https://dx.doi.org/10.3389/fimmu.2020.01815
58. Бычкова Н.В. Новая номенклатура аллергических заболеваний и реакций гиперчувствительности. Цитокины и воспаление. 2024; 21(1): 5-21.

Поступила 08.07.2025

Принята в печать 18.08.2025